What are the benefits and risks of microneedling?
Microneedling is best supported by evidence for atrophic acne scars, with consistent positive results across multiple randomised studies. For other skin concerns the indications are promising but less certain, and those with darker skin tones would be wise to discuss the risk of dark spots with a dermatologist beforehand.
Microneedling stimulates the skin by puncturing it with tiny needles. This triggers the production of collagen and elastin without seriously damaging the outer skin layer. As a result, recovery time is shorter than with more aggressive treatments such as laser therapy.
The strongest evidence concerns atrophic acne scars: nine randomised studies consistently confirm that microneedling improves them, both as a standalone treatment and in combination with other methods. The combination of microneedling with a chemical peel ranked highest in an analysis of 24 studies for improvement, patient satisfaction and treatment effect, outperforming microneedling alone, microneedling with platelet-rich plasma injections (PRP) or laser therapy. There are also positive indications for use in skin rejuvenation, pigmentation disorders (melasma), stretch marks, hereditary hair loss and excessive sweating, although the evidence for these is less clear-cut and study designs vary.
Temporary side effects are part of the treatment and are well documented: redness, swelling, pain, flaking and occasionally swollen lymph nodes. These typically resolve on their own within seven days. More noteworthy is post-inflammatory hyperpigmentation: dark spots can develop after the inflammation and may sometimes persist. This risk is greater in people with darker skin tones.
Serious complications are rare but do occur. Examples include parallel scarring caused by improper use of the device, a specific type of inflammatory skin reaction (granulomatous reaction) and, in exceptional cases, an allergic reaction affecting the whole body. These reports are isolated and do not give a picture of how frequently they occur in larger populations. Extra caution is warranted in the presence of an active skin infection, a metal allergy, or when substances are introduced into the skin that have not been approved for use in this way.
Research into microneedling still has gaps: studies are often small, short in duration and not always well designed. The evidence is most convincing for acne scars, but definitive conclusions for other applications are not yet possible.
This answer is based on multiple review studies and systematic analyses, including an analysis of 24 randomised studies specifically on acne scars. The findings regarding temporary side effects are well documented. For applications other than acne scars, the quality of the underlying study designs varies, and several researchers emphasise that larger, longer-term and better-controlled studies are still lacking. Serious complications are based on isolated reports, not on large-scale data.
Can GLP-1 agonists improve heart function?
GLP-1 agonists, and in particular semaglutide and tirzepatide, demonstrably reduce the risk of heart failure worsening in people with a specific form of heart failure; if you have this condition or type 2 diabetes, discuss with your cardiologist whether these agents are appropriate for you.
Do GLP-1 medications cause suicidal thoughts?
The available research gives no indication that GLP-1 medications cause suicidal thoughts; several large studies actually point to a lower risk. If you have doubts or concerns, discuss them with your doctor.